Mode
Text Size
Log in / Sign up

First-line suction aspiration versus combination technique for acute cerebral infarction in a multicenter trialImagine waking up unable to move one side of your body. This sudden loss of control is a stroke. Every minute counts when a blood vessel in the brain is blocked. Doctors race to open the vessel and save brain tissue. Time is the most important factor in recovery

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that specific outcome data were not reported for this trial comparing suction aspiration and combination technique.

This prospective, randomized, multicenter, noninferiority, open-label trial investigated the efficacy of first-line suction aspiration compared with first-line combination technique for the treatment of acute cerebral infarction, acute ischemic stroke, and large artery occlusion. The study population consisted of 1136 patients with acute cerebral infarction who were deemed amenable to both suction aspiration and combination techniques. The trial was conducted in a multicenter setting, though specific geographic locations were not reported. The study phase and publication type were not reported in the available data. The primary outcome assessed was successful recanalization, defined as a modified Thrombolysis in Cerebral Infarction scale score of 2b or greater, and a good clinical outcome, defined as a modified Rankin Scale score of 0 to 2, at 90 days. Secondary outcomes included the switching rate from the combination technique to suction aspiration, the switching rate from suction aspiration to the combination technique, procedural morbidity, nonprocedural morbidity, procedural mortality, and nonprocedural mortality. Safety and tolerability findings, including adverse events, serious adverse events, discontinuations, and overall tolerability, were not reported in the provided data. Follow-up for outcomes occurred at 90 days. No specific numerical results, effect sizes, confidence intervals, or p-values were provided for the primary or secondary outcomes in the input data. Consequently, the ability to compare these results to prior landmark studies in the therapeutic area of acute ischemic stroke recanalization is limited by the absence of quantitative outcome data. Methodological limitations and potential biases could not be detailed because the limitations field was empty in the source data. Funding sources and conflicts of interest were not reported. The practice relevance of these findings could not be determined from the provided information. Causality notes and certainty assessments were not reported. The absence of specific numerical data for the primary outcome of successful recanalization and good clinical outcome prevents a definitive statement on whether first-line suction aspiration is noninferior to the combination technique. Similarly, the switching rates between techniques and mortality/morbidity rates remain unknown. Without data on adverse events or tolerability, a safety profile cannot be constructed. Clinicians must interpret these findings with caution given the lack of reported outcome metrics. Questions regarding the optimal first-line mechanical thrombectomy strategy for this specific patient population remain unanswered until further data is published. The study design, while robust in its prospective randomized multicenter nature, yields inconclusive results due to the missing outcome data in the provided JSON. Future research or updated publications may provide the necessary quantitative details to inform clinical decision-making regarding the choice between suction aspiration and combination techniques for acute cerebral infarction.

Imagine waking up unable to move one side of your body. This sudden loss of control is a stroke. Every minute counts when a blood vessel in the brain is blocked. Doctors race to open the vessel and save brain tissue. Time is the most important factor in recovery.

Strokes are a leading cause of disability worldwide. Millions of people face this emergency every year. Current treatments work, but doctors want them to work better. Some patients still suffer damage even after the blockage is cleared. We need faster, safer ways to remove the clot.

The surprising shift in care

Surgeons use long tubes to reach the blockage. They pull out the clot using a vacuum or a basket. One method uses suction alone. The other mixes suction with a basket tool. Doctors used to think the mix was better. But here’s the twist. New technology suggests suction alone might be just as good. This could simplify the procedure significantly.

Think of the blocked artery like a clogged pipe. The suction tool acts like a powerful vacuum cleaner. It pulls the clot out in one piece. This reduces the risk of breaking the clot into smaller pieces. Broken pieces can travel deeper and cause more harm. Keeping the clot intact is key to safety.

The study design explained

A large group of patients will join this research. Over 1,100 people are expected to participate. They will be split into two equal groups. One group gets suction first. The other gets the combination method first. Doctors will watch what happens for 90 days. They track both recovery and safety closely.

What the researchers hope to prove

The main goal is to see if suction works well enough. They want to know if patients recover better with suction. Success means the patient can walk and care for themselves. They also check for safety during the procedure. The goal is to prove suction is not worse than the mix.

This doesn’t mean this treatment is available yet.

Experts say this comparison is vital for future care. If suction works just as well, it is simpler to use. Simpler tools can save time in busy emergency rooms. Less complexity means less chance for error during surgery.

This trial is still in progress. You cannot choose this method at a hospital today. Doctors will continue using the best proven methods now. Talk to your care team about stroke risk factors. Knowing the signs of a stroke saves lives.

Limitations to keep in mind

The study is not finished yet. Results might change as more patients join. Early data does not guarantee final outcomes. We must wait for the full report.

Scientists will wait for all data to be collected. Approval takes time to ensure safety for everyone. If successful, this could change how strokes are treated. The goal is to help more people walk again.

Study Details

Study typeRct
Sample sizen = 1,136
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: Recent advances in suction catheter technology suggest that suction aspiration may prevent thrombus fragmentation during mechanical thrombectomy. We therefore hypothesize that the radiological outcomes of suction aspiration as a first-line treatment would not be inferior to those of the combination technique. This study aims to evaluate the radiological and clinical outcomes of first-line suction aspiration compared with those of the first-line combination technique for large artery occlusion amenable to both modalities. METHODS: The COMPETE trial is a prospective, randomized, multicenter, noninferiority, open-label trial. A total of 1,136 patients will be randomized at a 1:1 ratio to either the suction aspiration or combination technique groups. RESULTS: The primary endpoints are successful recanalization (modified Thrombolysis in Cerebral Infarction scale score ≥ 2b) and a good clinical outcome (modified Rankin Scale score of 0-2) at 90 days after thrombectomy. The technical outcome is the switching rate from the combination technique to suction aspiration and from suction aspiration to the combination technique. The safety outcomes include procedural morbidity, nonprocedural morbidity, procedural mortality, and nonprocedural mortality. CONCLUSION: The COMPETE trial is expected to determine whether the use of suction aspiration as a first-line approach in patients with acute ischemic stroke is noninferior to the combination technique in achieving successful radiological and good clinical outcomes. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT06254755; CRIS (KCT0007726).
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.